Skip to main content

RATINGS CHANGES

Akorn (AKRX) - Get Akorn Inc. Report was downgraded to hold at Deutsche Bank. $24 price target. Earnings estimates were also cut, given lower expected ephedrine sales, Deutsche said. 

Albermarle (ALB) - Get Albemarle Corporation Report was downgraded to neutral from Citigroup. $112 price target. The company is already valued at 18x expected 2018 EBITDA, Citi said. 

Dow Chemical (DOW) - Get Dow, Inc. Report was upgraded to buy from hold at Jefferies. $75 price target. The merger creates multiple growth levers, Jefferies said. 

FedEx (FDX) - Get FedEx Corporation Report was upgraded to outperform at BMO Capital. $220 price target. The company is leveraged to an improving domestic industrial outlook, BMO said. 

GoPro (GPRO) - Get GoPro, Inc. Class A Report was downgraded to sell from neutral at Goldman Sachs. $6 price target. The company is facing challenges and burning through cash, Goldman said. 

TheStreet Recommends

Garmin (GRMN) - Get Garmin Ltd. Report was upgraded to neutral from sell at Goldman Sachs. $52 price target. The valuation is more attractive, as consensus estimates appear to have bottomed out, Goldman said. 

HP (HPQ) - Get HP Inc. Report was upgraded to outperform at Wells Fargo. Supplies growth and margin expansion could drive earnings upside, Wells said. 

Immersion (IMMR) - Get Immersion Corporation Report was downgraded to sell at TheStreet Ratings. You can view the full analysis from the report here: IMMR.

Universal Health (UHS) - Get Universal Health Services, Inc. Class B Report was upgraded to overweight from neutral at Piper Jaffray. $147 price target. The company has multiple growth levers, Piper said. 

United Therapeutics (UTHR) - Get United Therapeutics Corporation Report was downgraded to underperform from hold at Jefferies. $116 price target. A poll suggests potential competitive headwinds, Jefferies said. 

This article was written by a staff member of TheStreet.